图书简介

Section I: Basic Psychopharmacology; Chapter 1: A New Psychopharmacology Nomenclature; Chapter 2: Fundamentals of Neurobiology; Chapter 3: Fundamental Psychotropic Drug Structures and Mechanisms; Section II: Clinical Research Concepts for Psychopharmacology; Chapter 4: The Limitations of Clinical Experience; Chapter 5: Evidence-based Medicine: Pro and Con; Chapter 6: Maintenance Treatment Designs: Enriched, But Not Better; Chapter 7: Negative Studies: The Failure to Know What Isn’t Known; Chapter 8: Side Effects and Generalizability: Beyond p-values; Section III: Clinical Psychopharmacology of Drug Classes; Chapter 9: Monoamine Agonists (Antidepressants), Including Dopamine Agonists (Stimulants); Chapter 10: Dopamine Blockers (Antipsychotics); Chapter 11: Second Messenger Modifiers (Mood Stabilizers); Chapter 12: Gabaergic Agonists (Anxiolytics); Chapter 13: Other Agents (Glutamate Antagonists, Antihistamines, Melatonin Agonists, and Others); Chapter 14: Drug Class Summaries and Dosing Guidelines; Chapter 15: Index of Selected Commonly Used Drugs with Brief Summaries; Section IV: Clinical Psychopharmacology of Diseases and Syndromes; Chapter 16: Hippocratic Psychopharmacology: A Non-DSM Approach to Practice; Chapter 17: Beyond Symptoms: Diagnostic Validators; Chapter 18: The Concept of a Diagnostic Hierarchy; Chapter 19: Treatment of Affective Illnesses; Chapter 20: Anxiety Conditions; Chapter 21: Treatment of Personality; Chapter 22: Schizophrenia and Schizoaffective Conditions; Chapter 23: Addictions; Chapter 24: PTSD; Section V: Special Topics; Chapter 25: Carcinogenicity of Psychotropic Drugs; Chapter 26: Seasonal Affective Illness; Chapter 27: Suicide; Chapter 28: Children; Chapter 29: Older Persons; Chapter 30: Women; Chapter 31: Ethnic and Racial Groups; Chapter 32: Psychopharmacology in Medical Illnesses; Chapter 33: Polypharmacy; Chapter 34: Cultural Aspects of Psychopharmacology; Chapter 35: Treatment versus Enhancement; Chapter 36: The Pharmaceutical Industry; Chapter 37: Drug Discovery: Future Treatments; Section VI: The Art of Psychopharmacology; Chapter 38: The Diagnostic Interview; Chapter 39: The Med Check; Chapter 40: The Placebo Effect; Chapter 41: Legal Aspects of Psychopharmacology Practice; Chapter 42: Psychology of Psychopharmacology; Chapter 43: Innovation in Clinical Practice; Chapter 44: Clinical Cases; Chapter 45: Curbside Consults: Questions and Answers; Chapter 46: Key Research Studies in Clinical Psychopharmacology; Chapter 47: Historical Insights in Psychopharmacology; Chapter 48: Reflections on the Art of Psychopharmacology; Chapter 49: Ten Fallacies and Ten Truths of Psychopharmacology - Explained; Appendices; Appendix I: Mixed States; Appendix II: Bipolar or Borderline?; Appendix III: ADD in Children and Adults; Appendix IV: Schizoaffective Illness

Trade Policy 买家须知